top of page

Ambrx's CEO & CSO discuss the ADC space and recent #ESMO23 data

Dan O'Connor and Shawn Zhang describe Ambrx's HER2 and PSMA targeting antibody-drug conjugate programs, recent prostate cancer data at ESMO, and how they think about the competitive landscape.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page